Notably, ES BC in its set form consistently showed the highest upregulation of key osteogenic markers (ALPL, RUNX2, COL1A1), suggesting its strong potential for promoting mineralization and tissue regeneration. The gene discussed is RUNX2; the disease is breast cancer.